Search Results - "Fernández‐Clotet, Agnès"

Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn’s Disease by Ordás, Ingrid, Rimola, Jordi, Alfaro, Ignacio, Rodríguez, Sonia, Castro-Poceiro, Jesús, Ramírez-Morros, Anna, Gallego, Marta, Giner, Àngel, Barastegui, Rebeca, Fernández-Clotet, Agnès, Masamunt, Maica, Ricart, Elena, Panés, Julián

“…The magnetic resonance index of activity (MARIA) for Crohn’s disease (CD) is used to assess the activity of luminal CD. However, it has a number of practical…”
Get full text

Persistent damage on magnetic resonance enterography in patients with Crohn’s disease in endoscopic remission by Rimola, Jordi, Alfaro, Ignacio, Fernández‐Clotet, Agnès, Castro‐Poceiro, Jesús, Vas, Daniel, Rodríguez, Sonia, Masamunt, Maria Carme, Ordás, Ingrid, Ricart, Elena, Panés, Julián

“…Summary Background In Crohn's disease, it is essential to distinguish between persistent damage and abnormalities that can heal with anti‐inflammatory therapy…”
Get full text

Magnetic resonance enterography findings 46 weeks after initiation of biological therapy predict long‐term adverse outcomes in Crohn's disease by Fernández‐Clotet, Agnès, Ordás, Ingrid, Masamunt, Maria Carme, Caballol, Berta, Rodríguez, Sonia, Gallego, Marta, Barastegui, Rebeca, Saavedra, Anny Carolina, Panés, Julián, Ricart, Elena, Rimola, Jordi

“…Summary Background and Aims Magnetic resonance enterography (MRE) depicts transmural changes in response to biological treatment for Crohn's disease (CD);…”
Get full text

JAK Inhibition: The Most Promising Agents in the IBD Pipeline? by Fernández-Clotet, Agnès, Castro-Poceiro, Jesús, Panés, Julián

“…Under current therapeutic algorithms, half of the patients with moderate-severe ulcerative colitis or Crohn's disease fail in achieving a sustained remission…”
Get more information

Tofacitinib for the treatment of ulcerative colitis by Fernández-Clotet, Agnès, Castro-Poceiro, Jesús, Panés, Julián

“…New generations of small molecules are being developed for the treatment of ulcerative colitis. Among them, tofatinib (a Janus kinase (JAK) inhibitor) has…”
Get more information

Genetic biomarkers of methotrexate response and safety in Crohn's disease: Data from the Spanish ENEIDA registry by Salazar, Juliana, Garcia‐Planella, Esther, Fernández‐Clotet, Agnès, Esteve, Maria, Gisbert, Javier P., Busquets, David, Lucendo, Alfredo, Márquez, Lucía, Guardiola, Jordi, Martín‐Arranz, María Dolores, Iglesias, Eva, Monfort, David, Villoria, Albert, Cañete, Fiorella, Bell, Olga, Ricart, Elena, Zabana, Yamile, Chaparro, María, Domènech, Eugeni, Gordillo, Jordi

“…Aims Methotrexate (MTX) is used to induce and maintain remission in patients with steroid‐dependent Crohn's disease (CD). Despite its proven efficacy, its use…”
Get full text

Clinical features, therapeutic requirements and evolution of patients with Crohn’s disease and upper gastrointestinal involvement (CROHNEX study) by Sainz, Empar, Zabana, Yamile, Miguel, Isabel, Fernández‐Clotet, Agnès, Beltrán, Belén, Núñez, Laura, García, María José, Martín‐Arranz, María Dolores, Iglesias, Eva, Cañete, Fiorella, Gutiérrez, Ana, Piqueras, Marta, Pérez‐Martínez, Isabel, Bujanda, Luis, Rodríguez‐Lago, Iago, Casanova, María José, Navarro, Pablo, Vicente, Raquel, Merino, Olga, Algaba, Alicia, Rodríguez, Cristina, Huguet, José M., Fernández‐Bañares, Fernando, Domènech, Eugeni, Esteve, Maria

“…Summary Background Crohn's disease (CD) with upper gastrointestinal involvement (UGI) may have a more aggressive and refractory course. However, evidence on…”
Get full text

Early treatment with anti-tumor necrosis factor agents improves long-term effectiveness in symptomatic stricturing Crohn’s disease by Rodríguez-Lago, Iago, Hoyo, Javier Del, Pérez-Girbés, Alexandre, Garrido-Marín, Alejandro, Casanova, María José, Chaparro, María, Fernández-Clotet, Agnès, Castro-Poceiro, Jesús, García, María José, Sánchez, Sara, Ferreiro-Iglesias, Rocío, Bastón, Iria, Piqueras, Marta, Careda, Lola Esteba i Bech de, Mena, Raquel, Suárez, Cristina, Cordón, Joaquín Poza, López-García, Alicia, Márquez, Lucía, Arroyo, Maite, Alfambra, Erika, Sierra, Mónica, Cano, Noelia, Delgado-Guillena, Pedro, Morales-Alvarado, Víctor, Aparicio, Juan Carlos, Guerra, Iván, Aulló, Carolina, Merino, Olga, Arranz, Laura, Hidalgo, María Araceli, Llaó, Jordina, Plaza, Rocío, Molina, Gema, Torres, Paola, Pérez-Galindo, Pablo, Romero, María Giselle, Herrera-deGuise, Claudia, Armesto, Edisa, Mesonero, Francisco, Frago-Larramona, Santiago, Benítez, José Manuel, Calvo, Marta, Martín, María del Carmen López, Elorza, Ainara, Larena, Alejandro, Peña, Elena, Rodríguez-Grau, María del Carmen, Miguel-Criado, Jaime de, Botella, Belén, Olmos, José Antonio, López, Laura, Aguirre, Urko, Gisbert, Javier P.

“…Background There is limited evidence on the effectiveness of biological therapy in stricturing complications in patients with Crohn’s disease. Aim The study…”
Get full text

Fecal Calprotectin for Small Bowel Crohn's Disease: Is It a Cutoff Issue? by Romero-Mascarell, Cristina, Fernández-Esparrach, Gloria, Rodríguez-De Miguel, Cristina, Masamunt, Maria Carme, Rodríguez, Sonia, Rimola, Jordi, Urpí, Miguel, Casanova, Gherzon Simon, Ordás, Ingrid, Ricart, Elena, Caballol, Berta, Fernández-Clotet, Agnès, Panés, Julià, Llach, Josep, González-Suárez, Begoña

“…(1) Background: Fecal calprotectin (FC) correlates well with colonic inflammatory activity of Crohn’s disease (CD); data about relation of FC and small bowel…”
Get full text

Controlling leukocyte trafficking in IBD by Veny, Marisol, Fernández-Clotet, Agnès, Panés, Julián

“…[Display omitted] Inflammatory bowel disease (IBD) is characterized by the accumulation of immune cells, myeloid cells and lymphocytes in the inflamed…”
Get full text

Pre‐treatment magnetic resonance enterography findings predict the response to TNF‐alpha inhibitors in Crohn's disease by Rimola, Jordi, Fernàndez‐Clotet, Agnès, Capozzi, Nunzia, Rojas‐Farreras, Sònia, Alfaro, Ignacio, Rodríguez, Sonia, Masamunt, Maria‐Carme, Ricart, Elena, Ordás, Ingrid, Panés, Julian

“…Summary Background Identifying predictors of therapeutic response is the cornerstone of personalised medicine. Aim To identify predictors of long‐term healing…”
Get full text

Ustekinumab and vedolizumab for the prevention of postoperative recurrence of Crohn's disease: Results from the ENEIDA registry by Mañosa, Míriam, Fernández-Clotet, Agnès, Nos, Pilar, Martín-Arranz, María Dolores, Manceñido, Noemí, Carbajo, Ana, Hinojosa, Esther, Hernández-Camba, Alejandro, Muñoz-Pérez, Roser, Boscá-Watts, Maia, Calvo, Marta, Sierra-Ausín, Mónica, Sánchez-Rodríguez, Eugenia, Barreiro-de Acosta, Manuel, Núñez-Alonso, Alejandro, Zabana, Yamile, Márquez, Lucía, Gisbert, Javier P, Guardiola, Jordi, Sáinz, Empar, Delgado-Guillena, Pedro, Busquets, David, van Domselaar, Manuel, Girona, Eva, Lorente, Rufo, Casas-Deza, Diego, Huguet, José M., Maestro, Sergio, Cabello, M. José, Castro, Jesús, Iborra, Marisa, Cañete, Fiorella, Calafat, Margalida, Domènech, Eugeni

“…Anti-TNF agents are the only effective biological agents for the prevention of postoperative recurrence (POR) in Crohn's disease (CD). However, they are…”
Get full text

Magnetic Resonance Imaging Features Indicative of Permanent Colon Damage in Ulcerative Colitis: An Exploratory Study by Rimola, Jordi, Castro-Poceiro, Jesús, Sapena, Víctor, Aduna, Marta, Arevalo, Juan, Vera, Isabel, Pastrana, Miguel Ángel, Gallego, Marta, Masamunt, Maria Carme, Fernández-Clotet, Agnès, Ordás, Ingrid, Ricart, Elena, Panés, Julian

“…Abstract Background and Aims It is uncertain whether ulcerative colitis leads to accumulated bowel damage on cross-sectional image. We aimed to characterise…”
Get full text

De-escalating therapy in inflammatory bowel disease: Results from an observational study in clinical practice by Arenas, Alex, Moreta, María José, Ordás, Ingrid, Fernández-Clotet, Agnès, Caballol, Berta, Gallego, Marta, Vara, Alejandro, Barastegui, Rebeca, Giner, Angel, Prieto, Cristina, Masamunt, Maria Carme, Candia, Roberto, Ricart, Elena

“…Combination therapy with an immunomodulator (IMM) and an anti-TNF is commonly recommended in Crohn's disease (CD) and ulcerative colitis (UC) patients…”
Get more information

Mesenchymal stromal cells in the treatment of perianal fistulas in Crohn's disease by Castro-Poceiro, Jesús, Fernández-Clotet, Agnès, Panés, Julián

“…Significant unmet needs remain in patients with Crohn's disease and perianal fistulas. Mesenchymal stromal cells have potent immunomodulatory actions. The…”
Get full text

Clinical Characteristics, Associated Malignancies and Management of Primary Sclerosing Cholangitis in Inflammatory Bowel Disease Patients: A Multicentre Retrospective Cohort Study by Guerra, Ivan, Bujanda, Luis, Castro, Jesús, Merino, Olga, Tosca, Joan, Camps, Blau, Gutiérrez, Ana, Gordillo Ábalos, Jordi, de Castro, Luisa, Iborra, Marisa, Carbajo, Ana Y, Taxonera, Carlos, Rodríguez-Lago, Iago, Mesonero, Francisco, de Francisco, Ruth, Gómez-Gómez, Gonzalo J, Chaparro, María, Tardillo, Carlos A, Rivero, Montserrat, Algaba, Alicia, Martín Arranz, Eduardo, Cañete, Fiorella, Vicente, Raquel, Sicilia, Beatriz, Antolín, Beatriz, Prieto, Vanessa, Márquez, Lucía, Benítez, José M, Camo, Patricia, Piqueras, Marta, Gargallo, Carla J, Hinojosa, Esther, Huguet, José M, Pérez Calle, José L, Van Domselaar, Manuel, Rodriguez, Cristina, Calvet, Xavier, Muñoz-Villafranca, Carmen, García-Sepulcre, Mariana F, Munoz-Garrido, Patricia, Fernández-Clotet, Agnès, Gómez Irwin, Laura, Hernández, Sherly, Guardiola, Jordi, Sempere, Laura, González Muñoza, Carlos, Hernández, Vicent, Beltrán, Belén, Barrio, Jesús, Alba, Cristina, Moraleja, Irene, López-Sanromán, Antonio, Riestra, Sabino, Martínez Montiel, Pilar, Garre, Ana, Arranz, Laura, García, María José, Martín Arranz, María Dolores, Corsino, Pilar, Arias, Lara, Fernández-Salazar, Luis, Fernández-Pordomingo, Alejandra, Andreu, Montserrat, Iglesias, Eva, Ber, Yolanda, Mena, Raquel, Arroyo Villarino, María Teresa, Mora, María, Ruiz, Lucía, López-Serrano, Pilar, Blazquez, Isabel, Villoria, Albert, Fernández, María, Bermejo, Fernando, Banales, Jesus M, Domènech, Eugeni, Gisbert, Javier P

“…Abstract Background and Aims Primary sclerosing cholangitis [PSC] is usually associated with inflammatory bowel disease [IBD]. An increased risk of…”
Get full text

Adherence to endoscopic surveillance for advanced lesions and colorectal cancer in inflammatory bowel disease: an AEG and GETECCU collaborative cohort study by Ballester, Maria Pilar, Mesonero, Francisco, Flórez‐Diez, Pablo, Gómez, Concepción, Fuentes‐Valenzuela, Esteban, Martín, Noelia, Senosiain, Carla, Vela, Milagros, Fernández‐Clotet, Agnes, Pérez, Pablo, Rubín de Célix, Cristina, Calviño‐Suárez, Cristina, Hermida, Benito, Muñoz, Roser, González‐Vivo, Maria, Brunet, Eduard, Jiménez, Nuria, Botella, Belén, Yebra, Jorge, Suárez‐Ferrer, Cristina, Bouhmidi, Abdel, López‐Serrano, Antonio, Ponferrada, Ángel, Dueñas, Carmen, Mínguez, Miguel

“…Summary Background and Aims Patients with colonic inflammatory bowel disease (IBD) have a high risk of colorectal cancer (CRC). Current guidelines recommend…”
Get full text

Tacrolimus induces short‐term but not long‐term clinical response in inflammatory bowel disease by Rodríguez‐Lago, Iago, Castro‐Poceiro, Jesús, Fernández‐Clotet, Agnès, Mesonero, Francisco, López‐Sanromán, Antonio, López‐García, Alicia, Márquez, Lucía, Clos‐Parals, Ariadna, Cañete, Fiorella, Vicuña, Miren, Nantes, Óscar, Merino, Olga, Matallana, Virginia, Gordillo, Jordi, Elorza, Ainara, Vicente, Raquel, Casanova, María José, Ferreiro‐Iglesias, Rocío, Pérez‐Galindo, Pablo, Benítez, José Manuel, Taxonera, Carlos, García, María José, Martín, Eduardo, Aguirre, Urko, Gisbert, Javier P., Rodríguez‐Lago, I., Elorza, A., Castro‐Poceiro, J., Fernández‐Clotet, A., Mesonero, F., López‐Sanromán, A., López‐García, A., Márquez, L., Clos‐Parals, A., Cañete, F., Vicuña, M., Nantes, O., Merino, O., Matallana, V., Gordillo, J., Vicente, R., Casanova, M. J., Gisbert, J. P., Ferreiro‐Iglesias, R., Pérez‐Galindo, P., Manuel Benítez, J., Taxonera, C., García, M. J., Martín, E., Aguirre, U., Calafat, M., Muñoz, F., Miquel‐Cusachs, J. O., Sáinz, E.

“…Summary Background Tacrolimus is a calcineurin inhibitor commonly used for prophylaxis of rejection in renal and liver transplantation. There are limited but…”
Get full text

ADC Values for Detecting Bowel Inflammation and Biologic Therapy Response in Patients With Crohn Disease: A Post Hoc Prospective Trial Analysis by Rimola, Jordi, Fernandez-Clotet, Agnès, Capozzi, Nunzia, Caballol, Berta, Rodríguez, Sonia, Gallego, Marta, Masamunt, Maria Carme, Panés, Julian, Ricart, Elena, Ordás, Ingrid

“…New biologic agents for Crohn disease (CD) create a need for noninvasive disease markers. DWI may assess bowel inflammation without contrast agents. The…”
Get more information

Real‐world long‐term effectiveness of ustekinumab in Crohn's disease: results from the ENEIDA registry by Iborra, Marisa, Beltrán, Belén, Fernández‐Clotet, Agnes, Iglesias‐Flores, Eva, Navarro, Pablo, Rivero, Montserrat, Gutiérrez, Ana, Sierra‐Ausin, Mónica, Mesonero, Francisco, Ferreiro‐Iglesias, Rocío, Hinojosa, Joaquín, Calvet, Xavier, Sicilia, Beatriz, González‐Muñoza, Carlos, Antolín, Beatriz, González‐Vivo, María, Carbajo, Ana Y., García‐López, Santiago, Martín‐Cardona, Albert, Surís, Gerard, Martin‐Arranz, María Dolores, Francisco, Ruth, Cañete, Fiorella, Domènech, Eugeni, Nos, Pilar, Taxonera, C., Gomollón, F., Lorente, R., Rodríguez‐Lago, I., Forés‐Bosch, A., Bernardos, E., Ramos, L., Delgado‐Guillena, P., Hernández, A., Van Domselaar, M., Hervás, D., Casas‐Deza, D.

“…Summary Background Data on the long‐term administration of ustekinumab in recommended doses are limited. Aim To assess the real‐world, long‐term effectiveness…”
Get full text